FDA Investigator Brett D Weed
Brett D Weed has conducted inspections on 4 sites in 1 countries as of 17 Nov 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
17 Nov 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Brett D Weed:
Adam R Cooke,
Allen T Proxmire,
Arthur G Hurst,
Bonita S Chester,
Brett Weed,
Cassandra L Abellard,
Dr. Jason R Caballero,
Edward Lukeman,
Gideon N Esuzor,
Heather M Wheeler,
James P Lewis, Jr,
Jason F Chancey,
Jawaid Hamid,
Khalid M Khan,
Mancia R Walker,
Marla A Cassidy,
Noreen Muñiz,
Penny H Mccarver,
Rachael A Moliver,
Rashonda N Rucker,
Samantha J Bradley,
Seneca D Toms,
Shayla G Turnipseed,
Sonya M Edmonds,
Tracy R Ball,
Tyrico K English,
Viviana Matta,
Xiomara Copeland,
Young Kim
Brett D Weed's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2014 | FDA 483 | Exela Pharma Sciences, LLC. - Form 483, 2014-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more